ARTICLE | Company News
Taligen Therapeutics, Xoma deal
May 22, 2006 7:00 AM UTC
XOMA will use its Bacterial Cell Expression technology to develop and scale-up production processes for Taligen's FAb antibody fragment. Taligen plans to develop the compound for inflammatory diseases...